Your browser doesn't support javascript.
loading
Polysome Profiling of a Human Glioblastoma Reveals Intratumoral Heterogeneity.
Lupinacci, Fernanda Cristina Sulla; Kuasne, Hellen; Roffé, Martin; Vassalakis, Julia Avian; da Silva, Fernanda Ferreira; Santos, Tiago Góss; Andrade, Victor Piana; Sanematsu, Paulo; Martins, Vilma Regina; Rogatto, Silvia Regina; Hajj, Glaucia Noeli Maroso.
Afiliação
  • Lupinacci FCS; International Research Center, A.C.Camargo Cancer Center, National Institute of Science and Technology in Oncogenomics, São Paulo 01509-010, Brazil. flupinacci@accamargo.org.br.
  • Kuasne H; International Research Center, A.C.Camargo Cancer Center, National Institute of Science and Technology in Oncogenomics, São Paulo 01509-010, Brazil. khellenk@yahoo.com.br.
  • Roffé M; International Research Center, A.C.Camargo Cancer Center, National Institute of Science and Technology in Oncogenomics, São Paulo 01509-010, Brazil. mroffe@accamargo.org.br.
  • Vassalakis JA; International Research Center, A.C.Camargo Cancer Center, National Institute of Science and Technology in Oncogenomics, São Paulo 01509-010, Brazil. julia.vassalakis@accamargo.org.br.
  • da Silva FF; International Research Center, A.C.Camargo Cancer Center, National Institute of Science and Technology in Oncogenomics, São Paulo 01509-010, Brazil. fsilva@accamargo.org.br.
  • Santos TG; International Research Center, A.C.Camargo Cancer Center, National Institute of Science and Technology in Oncogenomics, São Paulo 01509-010, Brazil. tsantos@accamargo.org.br.
  • Andrade VP; Pathology Department, A.C.Camargo Cancer Center, National Institute of Science and Technology in Oncogenomics, São Paulo 01509-010, Brazil. victor.andrade@accamargo.org.br.
  • Sanematsu P; Neurosurgery Department, A.C.Camargo Cancer Center, National Institute of Science and Technology in Oncogenomics, São Paulo 01509-010, Brazil. psanematsu@yahoo.com.br.
  • Martins VR; International Research Center, A.C.Camargo Cancer Center, National Institute of Science and Technology in Oncogenomics, São Paulo 01509-010, Brazil. vmartins@accamargo.org.br.
  • Rogatto SR; Vejle Hospital, Institute of Regional Health Research, University of Southern, 5230 Odense, Denmark. silvia.regina.rogatto@rsyd.dk.
  • Hajj GNM; International Research Center, A.C.Camargo Cancer Center, National Institute of Science and Technology in Oncogenomics, São Paulo 01509-010, Brazil. ghajj@accamargo.org.br.
Int J Mol Sci ; 20(9)2019 May 02.
Article em En | MEDLINE | ID: mdl-31052505
ABSTRACT
Glioblastoma (GBM) is one of the most aggressive cancers, with median survival of less than 2 years. Despite of considerable advance in molecular classification of GBMs, no improvements in therapy have been described. The scenario is further complicated by tumor heterogeneity and the relationship among genetic, transcriptional and functional findings. Classically, gene expression has been evaluated by steady-state mRNA, however, this does not take translational control into consideration, which contributes considerably to the composition of the proteome. In this study, we evaluated the transcriptomic and translatomic signature of a GBM obtained from a single patient focusing in tumor heterogeneity. In a sampling of eight fragments, we investigated the translation rates, mTORC1 and ERK1/2 pathways and identified both total and polysome associated mRNAs. An increased translation rate was observed in fragments with high-grade histological features. High-grade histology was also associated with the expression of genes related to extracellular matrix (ECM) and angiogenesis, in both transcriptomes and translatomes. However, genes associated with epithelial to mesenchymal transition and stress response, were observed only in translatomes from high-grade fragments. Overall, our results demonstrate that isolation of translated mRNA can be used to identify biomarkers and reveal previously unrecognized determinants of heterogeneity in GBMs.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Neoplasias do Sistema Nervoso Central / Glioblastoma / Perfilação da Expressão Gênica Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Regulação Neoplásica da Expressão Gênica / Neoplasias do Sistema Nervoso Central / Glioblastoma / Perfilação da Expressão Gênica Tipo de estudo: Prognostic_studies Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article